197
Results-
Home PageCreated on : - Last modified on :
-
NewsEau Thermale Avène, a proud partner of Terres d'Hérault, a UNESCO Global Geopark since 2026Created on : - Last modified on :The Avène catchment area and its thermal hydrosystem have been recognised as a site of geological interest within the Terres d’Hérault Geopark, designated a “UNESCO Global Geopark”
-
Press ReleaseKinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre LaboratoriesCreated on : - Last modified on :• Kinnate has entered into an Asset Purchase Agreement (the “APA”) with Pierre Fabre Laboratories for global rights to exarafenib and other pan-RAF program assets.• The transaction is in furtherance of Kinnate’s previously announced pursuit of strategic alternatives.
-
Press ReleasePierre Fabre Laboratories and the EspeRare Foundation to be honored with the EURORDIS Company Award for Patient Engagement 2024, in their approach to co-developing a treatment for XLHED.Created on : - Last modified on :Castres (France), Geneva (Switzerland), 15 February 2024 – On February 20, International Ectodermal Dysplasias Awareness Day, Pierre Fabre Laboratories and the EspeRare Foundation will receive the EURORDIS Company Award for Patient Engagement 2024, at the EURORDIS Black Pearl Award Ceremony to be held in Brussels.
-
NewsroomCreated on : - Last modified on :
-
NewsHervé Hoppenot nommé Président du Conseil d’Administration de Pierre Fabre SACreated on : - Last modified on :Castres (France), May 26, 2026 - Pierre Fabre Participations, the Group’s parent holding company, has appointed Hervé Hoppenot as Chairman of the Board of Pierre Fabre SA. The Board of Directors, which met on May 21, approved this appointment. Hervé Hoppenot, who has served as a Board member of Pierre Fabre SA since January 15, 2024, succeeds Roch Doliveux, who has been appointed Vice Chairman of the Board.
-
NewsLaboratoires Pierre Fabre doubles production capacity at the Avène plant to drive the international growth of their flagship brandCreated on : - Last modified on :Avène (France), 28 May 2026 – As part of its new industrial master plan, Laboratoires Pierre Fabre has reached a major milestone by announcing a strategic investment of nearly €50 million to transform and expand its production site in Avène-les-Bains (Hérault in France), which is fully dedicated to the manufacturing and packaging of Eau Thermale Avène products.
-
Our GovernanceCreated on : - Last modified on :
-
About Pierre Fabre Laboratories OncologyCreated on : - Last modified on :
-
Business DevelopmentCreated on : - Last modified on :
Our Business Development & Licensing teams are made up of professionals capable of understanding all stages of pharmaceutical development and are available to discuss your innovative projects.
We take care of life by designing and developing innovative solutions inspired by consumers and patients, and contributing to the well-being of everyone from health to beauty.